Supracristal Ventricular Septal Defect
Supracristal (or doubly committed) ventricular septal defect (VSD) is the least common type of VSD in the Western Hemisphere, accounting for approximately 5-7% of such defects in this part of the world, including in the United States.  The location of the supracristal VSD, with its close proximity to the aortic valve, accounts for the common development of aortic insufficiency with this defect. Left-to-right shunting of blood through the defect is believed to progressively pull aortic valve tissue (especially the right coronary cusp) through a Venturi effect (see the image below). (See Pathophysiology.)
The crista supraventricularis can be considered synonymous with the infundibular (or conus) ventricular septum. It is the portion of the septum that separates the tricuspid and pulmonary valves. Defects above this part of the septum are referred to as supracristal defects. The term is generally reserved for defects lying immediately under the pulmonary valve. A defect, usually small, may occur within the conus septum, and, technically can be termed supracristal. (See Anatomy and Etiology.)
The infundibular (or conus) septum separates the tricuspid and pulmonary valves and accounts for the more superior placement of the pulmonary valve relative to the aortic valve. This portion of the septum also provides fairly rigid, muscular support for the aortic valve, especially the right coronary cusp. 
Numerous synonyms indicate the confusion often associated with describing supracristal ventricular septal defects (VSDs). The term supracristal may be misleading because the entire conus septum (or a major portion of the septum) may be missing. The term is commonly used, however, emphasizing the superior location of the defect along with its close approximation to the aortic and pulmonary valve leaflets. Lack of support for the right aortic leaflet is crucial to the natural history of this type of VSD. 
The plane of the conus septum in the right ventricular outflow tract lies almost perpendicular to that of the remainder of the septum. From a surgical perspective, a defect lying in the conus septum may not be visualized from the standard right atriotomy approach, looking through the tricuspid valve. [3, 5]
Unlike the more common perimembranous type of VSD, the supracristal VSD does not lie near the tricuspid valve. Unless the supracristal defect is large, extending inferiorly to the perimembranous septum, the tricuspid valve is not involved in partial closure of the defect.
Conduction system tissue lies inferior to the supracristal VSD. The conduction system may lie closer to a larger defect that crosses from the outlet septum into the perimembranous area.
The natural history of supracristal ventricular septal defects (VSDs) depends on the location and size of the defect. Patients with small, isolated supracristal VSDs may have no symptoms or signs of congestive failure such as might be observed with a large shunt. Progressive aortic insufficiency may develop later in life. Larger defects of the outlet septum frequently are associated with forms of aortic outflow obstruction (eg, coarctation, interrupted aortic arch). In such cases, symptoms of congestive heart failure and possible circulatory collapse appear early.
Patients with larger, isolated supracristal VSDs may develop congestive heart failure early in infancy due to a large left-to-right shunt. While spontaneous closure is not common,  a decrease in the magnitude of the left-to-right shunt may occur due to progressive prolapse into the defect of aortic valve tissue (the right coronary cusp or, possibly, the right sinus of Valsalva).  This valve leaflet prolapse is believed to result from the Venturi effect, as the high-velocity shunt flow produces negative pressure. Progressive distortion of the aortic leaflet or sinus as it prolapses into the VSD may lead to increasing aortic valve insufficiency.
The muscular outlet septum is primarily formed from the proximal endocardial ridges (similar to endocardial cushion tissue). Semilunar valve tissue and the actual connection between the septum and the arteries are formed by the more distal endocardial ridges. Extracardiac mesenchyme, derived from neural crest tissue, condenses as prongs (which act as a welding agent) with the most superior portion of the distal cushions to form the aortopulmonary septum.  By exposing neural crest tissue to homocysteine, supracristal ventricular septal defects (VSDs) have been induced in a high percentage of chick embryos. Disruption of apoptosis and myocardialization has been proposed to explain these findings. 
The frequent association between arch abnormalities and significant conal VSDs suggests a common mechanism involving a chromosome band 22q11 microdeletion. Deletions in this area have not been linked with isolated supracristal VSDs. 
As stated above, supracristal ventricular septal defect (VSD) accounts for approximately 5-7% of VSDs in the Western Hemisphere.  In the Eastern Hemisphere, however, the incidence of this condition is much higher, reaching 25% of all VSDs in patients from this part of the world, as supracristal VSDs are much more common in persons of Asian descent than in individuals of other races. Although the overall incidence of VSDs is no greater in Asians than in other groups, supracristal VSDs account for approximately 30% of VSDs in Asians.  Higher occurrence of the condition in this population has not been adequately explained, but one may assume that it is genetically determined.
The prognosis in patients with supracristal ventricular septal defect (VSD) should be considered good to excellent when the potential complication of aortic valve insufficiency is recognized and aggressively treated. [11, 12] Delayed recognition of or surgical treatment for progressive aortic valve insufficiency may lead to severe distortion of the aortic valve leaflet, making eventual valve replacement more likely. 
Morbidity or mortality in supracristal VSD is generally not the result of a large left-to-right shunt. Rather, it is caused by the development of aortic valve insufficiency. When progressive and severe, this results in left ventricular enlargement and eventual congestive heart failure, hence the admonition to address this problem early.
The appearance of aortic insufficiency as a complication of supracristal VSD is related to age. Young infants and toddlers presenting with supracristal VSDs are more likely to have findings of pulmonary overcirculation from the left-to-right shunt. While it may occur earlier in infancy, onset of aortic valve prolapse and progressive aortic insufficiency generally begins in children aged 6-10 years.
Patients with supracristal ventricular septal defect (VSD) are at increased risk of infective endocarditis. The risk is higher if aortic valve insufficiency is present.
The patient’s risk of developing infective endocarditis is higher for supracristal VSD with aortic insufficiency than it is for an isolated VSD. Patients and families should be educated on the importance of good oral and dental hygiene. Routine prophylaxis for dental or surgical procedures is no longer recommended unless there has been a prior episode of endocarditis. 
McDaniel NL, Gutgesell HP. Ventricular septal defects. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. 7th ed. Philadelphia: Wolters Kluwer/ Lippincott Williams & Wilkins; 2008. 667-682.
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Oct 9. 116(15):1736-54. [Medline]. [Full Text].
Anderson RH, Wilcox BR. The surgical anatomy of ventricular septal defects associated with overriding valvar orifices. J Card Surg. 1993 Mar. 8(2):130-42. [Medline].
Cheung YF, Chiu CS, Yung TC. Impact of preoperative aortic cusp prolapse on long-term outcome after surgical closure of subarterial ventricular septal defect. Ann Thorac Surg. 2002 Feb. 73(2):622-7. [Medline].
Ho SY, Baker EJ, Rigby ML. Color Atlas of Congenital Heart Disease: Morphologic and Clinical Correlations. St Louis, MO: Mosby-Wolfe; 1995.
Eroglu AG, Oztunc F, Saltik L, et al. Evolution of ventricular septal defect with special reference to spontaneous closure rate, subaortic ridge and aortic valve prolapse. Pediatr Cardiol. 2003 Jan-Feb. 24(1):31-5. [Medline].
Mori K, Matsuoka S, Tatara K, et al. Echocardiographic evaluation of the development of aortic valve prolapse in supracristal ventricular septal defect. Eur J Pediatr. 1995 Mar. 154(3):176-81. [Medline].
Gittenberger-De Groot AC, Poelmann RE. Normal and abnormal cardiac development. Moller JH, Hoffman JI, eds. Pediatric Cardiovascular Medicine. New York, NY: Churchill Livingstone; 2000. 3-20.
Boot MJ, Steegers-Theunissen RP, Poelmann RE, van Iperen L, Gittenberger-de Groot AC. Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res. 2004 Nov 1. 64(2):365-73. [Medline].
Momma K, Ando M, Matsuoka R, Joo K. Interruption of the aortic arch associated with deletion of chromosome 22q11 is associated with a subarterial and doubly committed ventricular septal defect in Japanese patients. Cardiol Young. 1999 Sep. 9(5):463-7. [Medline].
Leung MP, Beerman LB, Siewers RD, et al. Long-term follow-up after aortic valvuloplasty and defect closure in ventricular septal defect with aortic regurgitation. Am J Cardiol. 1987 Oct 1. 60(10):890-4. [Medline].
Rhodes LA, Keane JF, Keane JP, et al. Long follow-up (to 43 years) of ventricular septal defect with audible aortic regurgitation. Am J Cardiol. 1990 Aug 1. 66(3):340-5. [Medline].
Elgamal MA, Hakimi M, Lyons JM, Walters HL III. Risk factors for failure of aortic valvuloplasty in aortic insufficiency with ventricular septal defect. Ann Thorac Surg. 1999 Oct. 68(4):1350-5. [Medline].
Zuberbuhler JR. Ventricular septal defect. Clinical Diagnosis in Pediatric Cardiology. London, England: Churchill Livingstone; 1981. 39-45.
Cheng TO, Xie MX, Wang XF, Wang Y, Lu Q. Real-time 3-dimensional echocardiography in assessing atrial and ventricular septal defects: an echocardiographic-surgical correlative study. Am Heart J. 2004 Dec. 148(6):1091-5. [Medline].
Masaki N, Iwatsuka R, Nagahori W, et al. Three-dimensional echocardiography could distinguish a ventricular septal defect adjacent to asymptomatic ruptured sinus of valsalva aneurysm. J Cardiol. 2008 Apr. 51(2):139-43. [Medline].
Freedom RM, Mawson JB, Yoo SJ. Ventricular septal defect. Freedom RM, et al, eds. Congenital Heart Disease: Textbook of Angiocardiography. Futura Publishing Co; 1997. 189-218.
Yacoub MH, Khan H, Stavri G, et al. Anatomic correction of the syndrome of prolapsing right coronary aortic cusp, dilatation of the sinus of Valsalva, and ventricular septal defect. J Thorac Cardiovasc Surg. 1997 Feb. 113(2):253-60; discussion 261. [Medline].
Komai H, Naito Y, Fujiwara K, Noguchi Y, Nishimura Y, Uemura S. Surgical strategy for doubly committed subarterial ventricular septal defect with aortic cusp prolapse. Ann Thorac Surg. 1997 Oct. 64(4):1146-9. [Medline].
Lin K, Zhu D, Tao K, Gan C, Tang H, Feng Y, et al. Hybrid perventricular device closure of doubly committed subarterial ventricular septal defects: mid-term results. Catheter Cardiovasc Interv. 2013 Sep 1. 82(3):E225-32. [Medline].
Pan S, Xing Q, Cao Q, Wang P, Duan S, Wu Q, et al. Perventricular device closure of doubly committed subarterial ventral septal defect through left anterior minithoracotomy on beating hearts. Ann Thorac Surg. 2012 Dec. 94(6):2070-5. [Medline].
Leung MP, Chau KT, Chiu C, Yung TC, Mok CK. Intraoperative TEE assessment of ventricular septal defect with aortic regurgitation. Ann Thorac Surg. 1996 Mar. 61(3):854-60. [Medline].
Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol. 1996 Nov 1. 28(5):1083-91. [Medline].
Ira H Gessner, MD Professor Emeritus, Pediatric Cardiology, University of Florida College of Medicine
Ira H Gessner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, Society for Pediatric Research
Disclosure: Nothing to disclose.
Edward J Bayne, MD Assistant Professor, Division of Pediatric Cardiology, Emory University School of Medicine
Edward J Bayne, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society of Echocardiography, American College of Cardiology, American Heart Association
Disclosure: Nothing to disclose.
Howard S Weber, MD, FSCAI Professor of Pediatrics, Section of Pediatric Cardiology, Pennsylvania State University College of Medicine; Director of Interventional Pediatric Cardiology, Penn State Hershey Children’s Hospital
Howard S Weber, MD, FSCAI is a member of the following medical societies: Society for Cardiovascular Angiography and Interventions
Disclosure: Received income in an amount equal to or greater than $250 from: Abbott Medical .
Juan Carlos Alejos, MD Clinical Professor, Department of Pediatrics, Division of Cardiology, University of California, Los Angeles, David Geffen School of Medicine
Juan Carlos Alejos, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Medical Association, and International Society for Heart and Lung Transplantation
Disclosure: Actelion Honoraria Speaking and teaching
Hugh D Allen, MD Professor, Department of Pediatrics, Division of Pediatric Cardiology and Department of Internal Medicine, Ohio State University College of Medicine
Hugh D Allen, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, American Society of Echocardiography, Society for Pediatric Research, Society of Pediatric Echocardiography, and Western Society for Pediatric Research
Disclosure: Nothing to disclose.
Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Nothing to disclose.
Supracristal Ventricular Septal Defect
Research & References of Supracristal Ventricular Septal Defect|A&C Accounting And Tax Services